vs
Side-by-side financial comparison of Solventum (SOLV) and Molson Coors Beverage Company (TAP). Click either name above to swap in a different company.
Molson Coors Beverage Company is the larger business by last-quarter revenue ($3.1B vs $2.0B, roughly 1.6× Solventum). Molson Coors Beverage Company runs the higher net margin — 6.7% vs 3.2%, a 3.5% gap on every dollar of revenue. On growth, Molson Coors Beverage Company posted the faster year-over-year revenue change (6.1% vs -3.7%). Molson Coors Beverage Company produced more free cash flow last quarter ($1.1B vs $32.0M). Over the past eight quarters, Solventum's revenue compounded faster (-0.4% CAGR vs -9.8%).
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.
Molson Coors Beverage Company is a Canadian-American multinational drink and brewing company headquartered in Chicago, Illinois and Montreal, Quebec.
SOLV vs TAP — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.0B | $3.1B |
| Net Profit | $63.0M | $209.3M |
| Gross Margin | 51.4% | 31.0% |
| Operating Margin | 6.3% | — |
| Net Margin | 3.2% | 6.7% |
| Revenue YoY | -3.7% | 6.1% |
| Net Profit YoY | 103.2% | -28.7% |
| EPS (diluted) | $0.37 | $1.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $3.1B | ||
| Q4 25 | $2.0B | $3.1B | ||
| Q3 25 | $2.1B | $3.5B | ||
| Q2 25 | $2.2B | $3.7B | ||
| Q1 25 | $2.1B | $2.7B | ||
| Q4 24 | $2.1B | $3.2B | ||
| Q3 24 | $2.1B | $3.6B | ||
| Q2 24 | $2.1B | $3.8B |
| Q1 26 | — | $209.3M | ||
| Q4 25 | $63.0M | $238.3M | ||
| Q3 25 | $1.3B | $-2.9B | ||
| Q2 25 | $90.0M | $428.7M | ||
| Q1 25 | $137.0M | $121.0M | ||
| Q4 24 | $31.0M | $287.8M | ||
| Q3 24 | $122.0M | $199.8M | ||
| Q2 24 | $89.0M | $427.0M |
| Q1 26 | — | 31.0% | ||
| Q4 25 | 51.4% | 31.0% | ||
| Q3 25 | 54.2% | 33.7% | ||
| Q2 25 | 54.4% | 34.3% | ||
| Q1 25 | 53.8% | 31.6% | ||
| Q4 24 | 53.9% | 32.0% | ||
| Q3 24 | 56.0% | 33.4% | ||
| Q2 24 | 54.6% | 34.6% |
| Q1 26 | — | — | ||
| Q4 25 | 6.3% | 10.4% | ||
| Q3 25 | 80.6% | -98.5% | ||
| Q2 25 | 9.9% | 15.6% | ||
| Q1 25 | 7.3% | 6.9% | ||
| Q4 24 | 6.6% | 12.0% | ||
| Q3 24 | 13.2% | 12.5% | ||
| Q2 24 | 11.7% | 15.6% |
| Q1 26 | — | 6.7% | ||
| Q4 25 | 3.2% | 7.6% | ||
| Q3 25 | 60.4% | -84.0% | ||
| Q2 25 | 4.2% | 11.5% | ||
| Q1 25 | 6.6% | 4.5% | ||
| Q4 24 | 1.5% | 8.9% | ||
| Q3 24 | 5.9% | 5.5% | ||
| Q2 24 | 4.3% | 11.1% |
| Q1 26 | — | $1.22 | ||
| Q4 25 | $0.37 | $1.32 | ||
| Q3 25 | $7.22 | $-14.79 | ||
| Q2 25 | $0.51 | $2.13 | ||
| Q1 25 | $0.78 | $0.59 | ||
| Q4 24 | $0.18 | $1.39 | ||
| Q3 24 | $0.70 | $0.96 | ||
| Q2 24 | $0.51 | $2.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $878.0M | $896.5M |
| Total DebtLower is stronger | $5.0B | $3.9B |
| Stockholders' EquityBook value | $5.0B | $10.4B |
| Total Assets | $14.3B | $22.7B |
| Debt / EquityLower = less leverage | 1.00× | 0.37× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $896.5M | ||
| Q4 25 | $878.0M | $896.5M | ||
| Q3 25 | $1.6B | $950.2M | ||
| Q2 25 | $492.0M | $613.8M | ||
| Q1 25 | $534.0M | $412.7M | ||
| Q4 24 | $762.0M | $969.3M | ||
| Q3 24 | $772.0M | $1.0B | ||
| Q2 24 | $897.0M | $1.6B |
| Q1 26 | — | $3.9B | ||
| Q4 25 | $5.0B | $6.3B | ||
| Q3 25 | $5.1B | $6.3B | ||
| Q2 25 | $7.8B | $6.3B | ||
| Q1 25 | $7.9B | $6.2B | ||
| Q4 24 | $8.0B | $6.1B | ||
| Q3 24 | $8.1B | $6.2B | ||
| Q2 24 | $8.3B | $7.0B |
| Q1 26 | — | $10.4B | ||
| Q4 25 | $5.0B | $10.2B | ||
| Q3 25 | $5.0B | $10.3B | ||
| Q2 25 | $3.6B | $13.4B | ||
| Q1 25 | $3.3B | $13.1B | ||
| Q4 24 | $3.0B | $13.1B | ||
| Q3 24 | $3.2B | $13.3B | ||
| Q2 24 | $2.9B | $13.2B |
| Q1 26 | — | $22.7B | ||
| Q4 25 | $14.3B | $22.7B | ||
| Q3 25 | $14.0B | $22.9B | ||
| Q2 25 | $15.1B | $26.8B | ||
| Q1 25 | $14.5B | $25.9B | ||
| Q4 24 | $14.5B | $26.1B | ||
| Q3 24 | $14.7B | $26.6B | ||
| Q2 24 | $14.6B | $27.4B |
| Q1 26 | — | 0.37× | ||
| Q4 25 | 1.00× | 0.61× | ||
| Q3 25 | 1.03× | 0.61× | ||
| Q2 25 | 2.14× | 0.47× | ||
| Q1 25 | 2.43× | 0.47× | ||
| Q4 24 | 2.71× | 0.47× | ||
| Q3 24 | 2.54× | 0.47× | ||
| Q2 24 | 2.90× | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $95.0M | — |
| Free Cash FlowOCF − Capex | $32.0M | $1.1B |
| FCF MarginFCF / Revenue | 1.6% | 36.5% |
| Capex IntensityCapex / Revenue | 3.2% | — |
| Cash ConversionOCF / Net Profit | 1.51× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-10.0M | $2.5B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $95.0M | $540.7M | ||
| Q3 25 | $76.0M | $616.1M | ||
| Q2 25 | $169.0M | $718.3M | ||
| Q1 25 | $29.0M | $-90.7M | ||
| Q4 24 | $219.0M | $494.5M | ||
| Q3 24 | $169.0M | $521.2M | ||
| Q2 24 | $355.0M | $869.2M |
| Q1 26 | — | $1.1B | ||
| Q4 25 | $32.0M | $357.8M | ||
| Q3 25 | $-21.0M | $483.0M | ||
| Q2 25 | $59.0M | $555.0M | ||
| Q1 25 | $-80.0M | $-328.0M | ||
| Q4 24 | $92.0M | $383.4M | ||
| Q3 24 | $76.0M | $350.4M | ||
| Q2 24 | $297.0M | $691.7M |
| Q1 26 | — | 36.5% | ||
| Q4 25 | 1.6% | 11.4% | ||
| Q3 25 | -1.0% | 13.9% | ||
| Q2 25 | 2.7% | 14.8% | ||
| Q1 25 | -3.9% | -12.2% | ||
| Q4 24 | 4.4% | 11.8% | ||
| Q3 24 | 3.7% | 9.7% | ||
| Q2 24 | 14.3% | 18.0% |
| Q1 26 | — | — | ||
| Q4 25 | 3.2% | 5.9% | ||
| Q3 25 | 4.6% | 3.8% | ||
| Q2 25 | 5.1% | 4.4% | ||
| Q1 25 | 5.3% | 8.8% | ||
| Q4 24 | 6.1% | 3.4% | ||
| Q3 24 | 4.5% | 4.7% | ||
| Q2 24 | 2.8% | 4.6% |
| Q1 26 | — | — | ||
| Q4 25 | 1.51× | 2.27× | ||
| Q3 25 | 0.06× | — | ||
| Q2 25 | 1.88× | 1.68× | ||
| Q1 25 | 0.21× | -0.75× | ||
| Q4 24 | 7.06× | 1.72× | ||
| Q3 24 | 1.39× | 2.61× | ||
| Q2 24 | 3.99× | 2.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
TAP
Segment breakdown not available.
